Drug Profile
Aliskiren/valsartan - Novartis
Alternative Names: Rasival; ValturnaLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Novartis
- Class Antihypertensives; Branched-chain amino acids; Fumarates; Small molecules; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Hypertension
- No development reported Acute coronary syndromes
Most Recent Events
- 20 Jul 2012 Withdrawn for Hypertension in USA (PO)
- 17 May 2012 No development reported - Phase-II for Acute coronary syndromes in Canada (PO)
- 17 May 2012 No development reported - Phase-II for Acute coronary syndromes in European Union (PO)